UNEEG™ medical consists of a core team of directors and specialist. Between them, the core team possesses world-class competences within the areas of: diabetes, mathematics, project management and venture value creation. The core team works in close collaboration with a large number of stakeholders, all of whom are in possession of critical insight within a specific discipline. These stakeholders include: a Scientific Advisory Board, a number of participating hospitals, a technology network and major business partners within design and production.
UNEEG™ medical A/S Management Team
Henning Beck-Nielsen (Founder): Henning is a Professor and manager of the department of endocrinology at Odense University Hospital, and has been specializing in diabetes for the last 30 years. Henning has a high international reputation for his scientific work and has received a number of acknowledgements and prices. Latest he received The Hagedorn and Novo Nordisk prices. Henning is the original founder of HypoSafe A/S (today UNEEG™ medical A/S) and is, with his strong scientific ballast, responsible for the precision and validity of the projects research related results. Renowned in the world of diabetes, Henning ensures a high level of interest around the project.
Rasmus Stig Jensen (CEO): Rasmus Stig Jensen is educated as an engineer from Aalborg Universitet. Rasmus has approximately 20 years experience with project management and execution of large scale, cross-border R&D projects and client contracts. Among those, Rasmus has 10 years of experience in line management and project portfolio management. In taking the role of CEO, Rasmus is responsible for all daily operations at UNEEG™ medical A/S, with special focus on project management and delivery, and, managing relationships.
Claus Christiansen (Non-executive Director): Dr. Claus Henrik Christiansen holds a medical degree from the University of Copenhagen (1971) and has published more than 800 scientific articles. He is the executive director of Nordic Bioscience A/S, a company dedicated to the development, production and marketing of products within osteoporosis and diabetes. In addition, he is the founder of several biotechnology companies, including CCBR, Nordic Bioscience, Osteometer, MediTech and Synarc. He also serves on the board of various biomedical companies and is a member of numerous scientific advisory boards. Renowned in the biotech-business Claus manages the market and investment strategies.
Rasmus Elsborg Madsen (R&D Manager): Rasmus Elsborg Madsen has a Ph.D in mathematical modelling from the Institute for Mathematical Modelling (IMM), DTU. Furthermore, Rasmus has a degree as an electrical engineer from Århus Teknikum. Rasmus’s experience within the areas of neurological networks and pattern recognition, combined with his knowledge within the area of electronics, will ensure that the medical research results can be practically transferred to the commercial device. Rasmus provides a bridge between the medical findings and the technological solution.
Claus Juhl (Medical Manager): Dr. Claus B. Juhl, MD, PhD is a Medical Doctor from the University of Århus and did his Ph.D in Århus on the subject of insulin secretion in type 2 diabetes. Claus has done extensive research and has published numerous articles in international journals. Claus has more than 15 years of experience as a diabetes doctor which ensures a comprehensive understanding of the needs and problems of being a diabetes patient. As medical director of Hyposafe he designs and oversees the required clinical testing of the hyposafe devices.
Mads Frisenborg Marker (Manager QA and regulatory affairs): Mads Frisenborg Marker has a master’s degree in engineering from the Technical University of Denmark (DTU) and an MBA degree from the Bocconi Business school (Italy). Mads has worked 7 years in the Management consulting business and has worked as project manager on numerous international projects focused on organizational alignment and performance measurement . In his current role Mads handles all quality and regulatory issues in UNEEG™ medical as well as liaisons with business partners.
Knud Stampe (Marketing Manager): Knud Stampe holds a M.Sc. in Economics and Business Administration from the University of Southern Denmark. Knud has a solid background in Marketing and Sales from more than 15 years as marketing professional in the life sciences business. Among his achievements Knud has been heading the marketing of blockbuster pharmaceutical drugs. Knud has had various product line responsibilities on national level and has worked in the Nordics as well as internationally. In his role at UNEEG™ medical Knud is responsible for building the marketing and sales organization. In addition Knud is responsible for building an international network with key stakeholders within the diabetes area as well as participating in general business development.